# Robert B. Colvin

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/robert-b-colvin/

## Facts

| Field | Value |
| --- | --- |
| Citations | 54,306 |
| Field | Renal Transplantation Outcomes and Treatments |
| h-index | 111 |
| i10-index | 390 |
| Last Known Institution | Harvard University |
| OpenAlex ID | https://openalex.org/A5019248592 |
| ORCID iD | 0000-0002-4493-4150 |
| Works | 669 |

## Researcher papers

Showing 12 of 15.

- [The Banff 97 working classification of renal allograft pathology](https://scholariq.org/papers/the-banff-97-working-classification-of-renal-allograft-pathology/)
- [Banff 07 Classification of Renal Allograft Pathology: Updates and Future Directions](https://scholariq.org/papers/banff-07-classification-of-renal-allograft-pathology-updates-and-future/)
- [Reactivity of a monoclonal antibody with human ovarian carcinoma.](https://scholariq.org/papers/reactivity-of-a-monoclonal-antibody-with-human-ovarian-carcinoma/)
- [International standardization of criteria for the histologic diagnosis of renal allograft rejection: The Banff working classification of kidney transplant pathology](https://scholariq.org/papers/international-standardization-of-criteria-for-the-histologic-diagnosis-of-renal/)
- [Banff 2013 Meeting Report: Inclusion of C4d-Negative Antibody-Mediated Rejection and Antibody-Associated Arterial Lesions](https://scholariq.org/papers/banff-2013-meeting-report-inclusion-of-c4d-negative-antibody-mediated-rejection/)
- [Antibody-Mediated Rejection Criteria - an Addition to the Banff ’97 Classification of Renal Allograft Rejection](https://scholariq.org/papers/antibody-mediated-rejection-criteria-an-addition-to-the-banff-97-classification/)
- [The Banff 2017 Kidney Meeting Report: Revised diagnostic criteria for chronic active T cell–mediated rejection, antibody-mediated rejection, and prospects for integrative endpoints for next-generation clinical trials](https://scholariq.org/papers/the-banff-2017-kidney-meeting-report-revised-diagnostic-criteria-for-chronic/)
- [Revision of the International Society of Nephrology/Renal Pathology Society classification for lupus nephritis: clarification of definitions, and modified National Institutes of Health activity and chronicity indices](https://scholariq.org/papers/revision-of-the-international-society-of-nephrology-renal-pathology-society/)
- [Diagnosis and management of renal cell carcinomaA clinical and pathologic study of 309 cases](https://scholariq.org/papers/diagnosis-and-management-of-renal-cell-carcinomaa-clinical-and-pathologic-study/)
- [HLA-Mismatched Renal Transplantation without Maintenance Immunosuppression](https://scholariq.org/papers/hla-mismatched-renal-transplantation-without-maintenance-immunosuppression/)
- [The Banff 2019 Kidney Meeting Report (I): Updates on and clarification of criteria for T cell– and antibody-mediated rejection](https://scholariq.org/papers/the-banff-2019-kidney-meeting-report-i-updates-on-and-clarification-of-criteria/)
- [2016 Comprehensive Update of the Banff Working Group on Liver Allograft Pathology: Introduction of Antibody-Mediated Rejection](https://scholariq.org/papers/2016-comprehensive-update-of-the-banff-working-group-on-liver-allograft/)

## Researcher topics

- [Renal Transplantation Outcomes and Treatments](https://scholariq.org/topics/renal-transplantation-outcomes-and-treatments/)
- [Organ Transplantation Techniques and Outcomes](https://scholariq.org/topics/organ-transplantation-techniques-and-outcomes/)
- [Xenotransplantation and immune response](https://scholariq.org/topics/xenotransplantation-and-immune-response/)
- [Renal Diseases and Glomerulopathies](https://scholariq.org/topics/renal-diseases-and-glomerulopathies/)
- [T-cell and B-cell Immunology](https://scholariq.org/topics/t-cell-and-b-cell-immunology/)

## Researcher university

- [Harvard University](https://scholariq.org/institutions/harvard-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.